Review





Similar Products

phosphorylated egfr p egfr  (Cell Signaling Technology Inc)
94
Cell Signaling Technology Inc phosphorylated egfr p egfr
Phosphorylated Egfr P Egfr, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/phosphorylated egfr p egfr/product/Cell Signaling Technology Inc
Average 94 stars, based on 1 article reviews
phosphorylated egfr p egfr - by Bioz Stars, 2026-02
94/100 stars
  Buy from Supplier
phosphorylated p erbb2 tyr1248  (Cell Signaling Technology Inc)
95
Cell Signaling Technology Inc phosphorylated p erbb2 tyr1248
The c.1253 T > C (p.I418T) mutation has no effect on ERBB3 expression and interaction with <t>ERBB2,</t> whereas the c.3182dupA (p.N1061Kfs*16) mutation produces a novel truncated protein. a Western blotting results using anti-Myc antibody to detect ERBB3 in lysates of HEK293T cells transfected with 2 μg empty vector (EV) or WT, c.1253 T > C (M1), or c.3182dupA (M2) plasmids. b Results of co-immunoprecipitation to detect the interaction between ERBB2 and WT or I418T (M1) mutant ERBB3
Phosphorylated P Erbb2 Tyr1248, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/phosphorylated p erbb2 tyr1248/product/Cell Signaling Technology Inc
Average 95 stars, based on 1 article reviews
phosphorylated p erbb2 tyr1248 - by Bioz Stars, 2026-02
95/100 stars
  Buy from Supplier
antibodies against phosphorylated (p)-tyr1248 her2  (Cell Signaling Technology Inc)
90
Cell Signaling Technology Inc antibodies against phosphorylated (p)-tyr1248 her2
The c.1253 T > C (p.I418T) mutation has no effect on ERBB3 expression and interaction with <t>ERBB2,</t> whereas the c.3182dupA (p.N1061Kfs*16) mutation produces a novel truncated protein. a Western blotting results using anti-Myc antibody to detect ERBB3 in lysates of HEK293T cells transfected with 2 μg empty vector (EV) or WT, c.1253 T > C (M1), or c.3182dupA (M2) plasmids. b Results of co-immunoprecipitation to detect the interaction between ERBB2 and WT or I418T (M1) mutant ERBB3
Antibodies Against Phosphorylated (P) Tyr1248 Her2, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/antibodies against phosphorylated (p)-tyr1248 her2/product/Cell Signaling Technology Inc
Average 90 stars, based on 1 article reviews
antibodies against phosphorylated (p)-tyr1248 her2 - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier
phosphorylated (p)-tyr1248-her2 antibody  (Millipore)
90
Millipore phosphorylated (p)-tyr1248-her2 antibody
Table 1
Phosphorylated (P) Tyr1248 Her2 Antibody, supplied by Millipore, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/phosphorylated (p)-tyr1248-her2 antibody/product/Millipore
Average 90 stars, based on 1 article reviews
phosphorylated (p)-tyr1248-her2 antibody - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier
phosphorylated (p)tyr1248-her2 antibody  (Millipore)
90
Millipore phosphorylated (p)tyr1248-her2 antibody
Table 1
Phosphorylated (P)Tyr1248 Her2 Antibody, supplied by Millipore, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/phosphorylated (p)tyr1248-her2 antibody/product/Millipore
Average 90 stars, based on 1 article reviews
phosphorylated (p)tyr1248-her2 antibody - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier

Image Search Results


The c.1253 T > C (p.I418T) mutation has no effect on ERBB3 expression and interaction with ERBB2, whereas the c.3182dupA (p.N1061Kfs*16) mutation produces a novel truncated protein. a Western blotting results using anti-Myc antibody to detect ERBB3 in lysates of HEK293T cells transfected with 2 μg empty vector (EV) or WT, c.1253 T > C (M1), or c.3182dupA (M2) plasmids. b Results of co-immunoprecipitation to detect the interaction between ERBB2 and WT or I418T (M1) mutant ERBB3

Journal: Orphanet Journal of Rare Diseases

Article Title: Biallelic ERBB3 loss-of-function variants are associated with a novel multisystem syndrome without congenital contracture

doi: 10.1186/s13023-019-1241-z

Figure Lengend Snippet: The c.1253 T > C (p.I418T) mutation has no effect on ERBB3 expression and interaction with ERBB2, whereas the c.3182dupA (p.N1061Kfs*16) mutation produces a novel truncated protein. a Western blotting results using anti-Myc antibody to detect ERBB3 in lysates of HEK293T cells transfected with 2 μg empty vector (EV) or WT, c.1253 T > C (M1), or c.3182dupA (M2) plasmids. b Results of co-immunoprecipitation to detect the interaction between ERBB2 and WT or I418T (M1) mutant ERBB3

Article Snippet: Antibodies against ERBB2 (#2242), phosphorylated (p-)ERBB2 (Tyr1248) (#2247), ERBB3 (C-terminus) (#12708), p-ERBB3 (Tyr1289) (#4791), ERK (#4695), p-ERK (#4370), AKT (#4685), p-AKT (#4060), GFP (#2555), Myc (#2272), and GAPDH (#5174) were purchased from Cell Signaling Technology.

Techniques: Mutagenesis, Expressing, Western Blot, Transfection, Plasmid Preparation, Immunoprecipitation

ERBB3 variants lack the capacity to activate PI3K/AKT and ERK signaling pathways. a Immunoblot analysis was performed using indicated antibodies to determine the effects of WT or mutant ERBB3 on PI3K/AKT and ERK pathway activation. To induce protein phosphorylation, HEK293T cells were treated with 10 ng/ml NRG-1β for 30 min after transfection with empty vector (EV), WT, M1, M2, or M3 (V104 L) plasmids. b–e Quantitative analysis of p-ERK, p-AKT, p-ERBB2, and p–ERBB3 expression. * P < 0.05, ** P < 0.01, *** P < 0.001 vs. WT

Journal: Orphanet Journal of Rare Diseases

Article Title: Biallelic ERBB3 loss-of-function variants are associated with a novel multisystem syndrome without congenital contracture

doi: 10.1186/s13023-019-1241-z

Figure Lengend Snippet: ERBB3 variants lack the capacity to activate PI3K/AKT and ERK signaling pathways. a Immunoblot analysis was performed using indicated antibodies to determine the effects of WT or mutant ERBB3 on PI3K/AKT and ERK pathway activation. To induce protein phosphorylation, HEK293T cells were treated with 10 ng/ml NRG-1β for 30 min after transfection with empty vector (EV), WT, M1, M2, or M3 (V104 L) plasmids. b–e Quantitative analysis of p-ERK, p-AKT, p-ERBB2, and p–ERBB3 expression. * P < 0.05, ** P < 0.01, *** P < 0.001 vs. WT

Article Snippet: Antibodies against ERBB2 (#2242), phosphorylated (p-)ERBB2 (Tyr1248) (#2247), ERBB3 (C-terminus) (#12708), p-ERBB3 (Tyr1289) (#4791), ERK (#4695), p-ERK (#4370), AKT (#4685), p-AKT (#4060), GFP (#2555), Myc (#2272), and GAPDH (#5174) were purchased from Cell Signaling Technology.

Techniques: Protein-Protein interactions, Western Blot, Mutagenesis, Activation Assay, Phospho-proteomics, Transfection, Plasmid Preparation, Expressing

Table 1

Journal:

Article Title: Reduced Dose and Intermittent Treatment with Lapatinib and Trastuzumab for Potent Blockade of the HER Pathway in HER-2/ neu Overexpressing Breast Tumor Xenografts

doi: 10.1158/1078-0432.CCR-10-1905

Figure Lengend Snippet: Table 1

Article Snippet: Antibodies used for immunoblotting were to phosphorylated (p)-Tyr1248-HER2 (Millipore, Billerica, MA); total HER2, total and phosphorylated forms of AKT (Thr308), ERK1,2 MAPK (Thr202/Tyr204) and β-actin (Cell Signaling Technology, Beverly, CA.)

Techniques: